The Establishment of Dendritic Cell-Tumor Fusion Vaccines for Hormone Refractory Prostate Cancer Cell

PURPOSE: Dendritic cell (DC)-based tumor vaccine is an attractive modality for the treatment of hormone-refractory prostate cancer (HRPC) because it has some efficacy and few side effects in patients with poor general conditions. The aim of this study was to establish which is the most effective DC...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Kim, Tae-Beom, Park, Ho Ki, Chang, Joo Hyun, Choi, In Ho, Kim, Khae Hawn, Yoon, Sang Jin, Lee, Min Sung, Jung, Han, Kim, Choung-Soo
Format: Artigo
Sprache:Inglês
Veröffentlicht: The Korean Urological Association 2010
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2855480/
https://ncbi.nlm.nih.gov/pubmed/20414428
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4111/kju.2010.51.2.139
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge